Benefits of Alpha-Lipoic Acid

Evidence-Based Benefits

• Diabetic neuropathy — the SYDNEY 2 trial (Ziegler et al., 2006) demonstrated that 600mg IV ALA daily for 5 weeks significantly reduced neuropathic symptoms including pain, burning, and numbness compared to placebo
• Universal antioxidant — ALA is unique in being both hydrophilic and lipophilic, allowing it to scavenge free radicals in every cellular compartment; it also regenerates spent vitamins C, E, glutathione, and CoQ10
• Blood sugar control — Ansar et al. (2011) showed 300mg ALA daily for 8 weeks significantly reduced fasting glucose and HbA1c in type 2 diabetes patients
• Mitochondrial cofactor — ALA is required for the function of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, two critical enzymes in the citric acid cycle for energy production
• Heavy metal chelation — ALA binds mercury, arsenic, and other heavy metals, supporting detoxification; this property has both benefits and cautions (can mobilize stored metals)

What the Research Says

Alpha-lipoic acid has one of the longest clinical track records among longevity-adjacent supplements. The SYDNEY 2 trial (Ziegler et al., 2006) is the landmark study, a multicenter RCT demonstrating clear benefits for diabetic neuropathy at 600mg daily. Ansar et al. (2011) confirmed blood sugar benefits. Shay et al. (2009) published a comprehensive review establishing ALA's role as a mitochondrial cofactor and universal antioxidant. The R-enantiomer versus racemic debate is important — R-ALA is the naturally occurring, more potent form, and stabilized Na-R-ALA addresses the polymerization instability of pure R-ALA. ALA's ability to regenerate other antioxidants makes it a cornerstone of comprehensive antioxidant protocols.

Related Conditions